At a glance
- Originator Bayer
- Class Antiallergics; Antiasthmatics; Quinolines; Small molecules
- Mechanism of Action 5-lipoxygenase activating protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Bronchitis; Chronic obstructive pulmonary disease; Ischaemic heart disorders; Rheumatoid arthritis